Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06324981 · ClinicalTrials.gov registry record · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
A NA study of Cardiovascular Diseases and Lifestyle Factors, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 2,100
- Enrollment target
- 3
- Study locations
NCT06324981: Recruiting NA study of Cardiovascular Diseases and Lifestyle Factors, sponsored by University of Colorado, Denver.
NCT06324981 is a NA study of Cardiovascular Diseases and Lifestyle Factors that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 2,100 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06324981, a NA study of Cardiovascular Diseases and Lifestyle Factors, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive pharmacist support. To measure cardiovascular risk factors, the investigators are using the American Heart Association's Life's Essential 8 (LE8) factors-blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking. This study focuses on improving cardiovascular risk factors for individuals facing health disparities, such as ethnic minorities, limited English proficiency, and low-income groups. These groups are more likely to be seriously affected by cardiovascular diseases. Self-management, or an individual's roles in managing their own chronic disease, includes lifestyle changes, medication adherence. Improving patients' self-management has been shown to improve health behaviors, better disease control and improved patient outcomes. The main question this study aims to answer is if one of the strategies (texting, chatbot, or chatbot with pharmacist support) may improve patient self-management and patient outcomes. The investigators will enroll up to 2,100 patients from three health systems that serve large populations experiencing health disparities: Denver Health, Salud Family Health Centers, and STRIDE Community Health Center. The results might help researchers and health care systems find the best ways to involve patients with health disparities to managing their chronic cardiovascular disease.
Primary Outcome
The primary outcome is change in Life's Essential 8 risk score from baseline and 12 months following randomization. The Life's Essential 8 (LE8) is a cardiovascular health score that uses a 0-100 scale. The score is calculated based on a participant's adherence to eight healthy lifestyle components: diet, physical activity, smoking habits, body mass index, total cholesterol, blood sugar, blood pressure, and sleep. Each component has scoring algorithm ranging from 0 to 100 points, allowing gener
Conditions Studied
Interventions
- BEHAVIORAL Generic text messages
- BEHAVIORAL Interactive AI chatbot text messaging
- BEHAVIORAL Proactive pharmacist support
Study Locations (3)
Colorado
- Denver Health - Denver
- Salud Family Health Centers - Fort Lupton
- STRIDE Community Health Centers - Wheat Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,100 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT06324981 shows while recruiting
NCT06324981 is an interventional study that assigns participants to a tested intervention. Its 2,100 participants enrollment target places it among the larger protocols in the corpus, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Generic text messages is the first listed.
NCT06324981 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06324981 about?
NCT06324981 is a clinical study titled "Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors". The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot mes...
What is the current status of trial NCT06324981?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,100 participants. The study started on 2024-02-26. Estimated completion is 2028-06.
What conditions does trial NCT06324981 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Lifestyle Factors.
What interventions are being tested in trial NCT06324981?
The interventions under investigation include: Generic text messages (BEHAVIORAL), Interactive AI chatbot text messaging (BEHAVIORAL), Proactive pharmacist support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06324981?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06324981 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06324981's enrollment target sits among peer trials
2,100 37th of 300 higher than 264 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06482957 · 2,100 participants
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI